Schizophrenia
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
We resequenced the putative promoter region and all the exons of the DLGAP2 gene in 523 patients with schizophrenia and 596 non-psychotic controls from Taiwan and conducted a case-control association analysis.
|
24416398 |
2014 |
Schizophrenia
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
The findings of this study provide first evidence of DNA methylation levels in DLGAP2 associated with SCZ with TD in Chinese population.
|
30504779 |
2018 |
Kidney Failure, Chronic
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association studies suggest that APOL1-environment interactions more likely trigger kidney disease in African Americans with nondiabetic nephropathy than strong APOL1-second gene interactions.
|
29885931 |
2018 |
Leukemia, Myelocytic, Acute
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide haplotype association study identify the FGFR2 gene as a risk gene for acute myeloid leukemia.
|
27903959 |
2017 |
Narcolepsy
|
0.100 |
GeneticVariation
|
disease |
GWASDB |
Genome-wide association database developed in the Japanese Integrated Database Project.
|
19629137 |
2009 |
Triglycerides measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Amerindian-specific regions under positive selection harbour new lipid variants in Latinos.
|
24886709 |
2014 |
Prostate carcinoma
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Radiogenomics Consortium Genome-Wide Association Study Meta-Analysis of Late Toxicity After Prostate Cancer Radiotherapy.
|
31095341 |
2020 |
Age at menarche
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genome-wide association study of age at menarche in African-American women.
|
23599027 |
2013 |
Age at menarche
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Genome-wide association study of age at menarche in African-American women.
|
23599027 |
2013 |
Chronic Kidney Diseases
|
0.100 |
GeneticVariation
|
group |
GWASCAT |
Genome-wide association studies suggest that APOL1-environment interactions more likely trigger kidney disease in African Americans with nondiabetic nephropathy than strong APOL1-second gene interactions.
|
29885931 |
2018 |
Alcoholic Intoxication, Chronic
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Through epigenome-wide association analysis of DNA methylation from human brain tissues, we identified a differentially methylated region, DMR-DLGAP2, associated with alcohol dependence.
|
31745236 |
2019 |
Tardive Dyskinesia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The findings of this study provide first evidence of DNA methylation levels in DLGAP2 associated with SCZ with TD in Chinese population.
|
30504779 |
2018 |
Drug-induced tardive dyskinesia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The findings of this study provide first evidence of DNA methylation levels in DLGAP2 associated with SCZ with TD in Chinese population.
|
30504779 |
2018 |
Autistic Disorder
|
0.320 |
Biomarker
|
disease |
BEFREE |
The 8p23.3 region contains the autism candidate gene DLGAP2, which can contribute to autism when disrupted [Marshall et al.
|
28407363 |
2017 |
Autistic Disorder
|
0.320 |
Biomarker
|
disease |
CTD_human |
Functional impact of global rare copy number variation in autism spectrum disorders.
|
20531469 |
2010 |
Autistic Disorder
|
0.320 |
Biomarker
|
disease |
BEFREE |
Discs-Large Associated Protein 2 (<i>DLGAP2)</i>, involved in synapse organization, neuronal signaling, and strongly implicated in autism, exhibited significant hypomethylation (p < 0.05) at 17 CpG sites in human sperm.
|
31451081 |
2020 |
Schizophrenia
|
0.320 |
Biomarker
|
disease |
PSYGENET |
We resequenced the putative promoter region and all the exons of the DLGAP2 gene in 523 patients with schizophrenia and 596 non-psychotic controls from Taiwan and conducted a case-control association analysis.
|
24416398 |
2014 |
Non-Small Cell Lung Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
RP11-397D12.4, AC007403.1, and ERICH1-AS1 may be potential biomarkers for predicting the tumorigenesis of NSCLC in the future.
|
26393913 |
2015 |
polyps
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
<b>Abbreviations</b>: Ams1: α-mannosidase; Ape1: aminopeptidase I; Ape3: aminopeptidase Y; Ape4: aspartyl aminopeptidase; Atg: autophagy related; Cps1: carboxypeptidase S; CTNS: cystinosin, lysosomal cystine transporter; CTSA: cathepsin A; CTSD: cathepsin D; Cvt: cytoplasm-to-vacuole targeting; Dap2: dipeptidyl aminopeptidase B; GS-bimane: glutathione-<i>S</i>-bimane; GSH: glutathione; LDs: lipid droplets; MVB: multivesicular body; PAS: phagophore assembly site; Pep4: proteinase A; PolyP: polyphosphate; Prb1: proteinase B; Prc1: carboxypeptidase Y; V-ATPase: vacuolar-type proton-translocating ATPase; VTC: vacuolar transporter chaperone.
|
30422029 |
2019 |
Developmental delay (disorder)
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Furthermore, following a detailed review of the potential associations between the genes located from 8p23.2 to 8pter and their clinical significance, it was hypothesized that DLG associated protein 2, ceroid‑lipofuscinosis neuronal 8, Rho guanine nucleotide exchange factor 10 and CUB and sushi multiple domains 1 may be candidate genes for DD/ID, microcephaly and neurobehavioral disorders.
|
28901431 |
2017 |
Global developmental delay
|
0.010 |
Biomarker
|
disease |
BEFREE |
Furthermore, following a detailed review of the potential associations between the genes located from 8p23.2 to 8pter and their clinical significance, it was hypothesized that DLG associated protein 2, ceroid‑lipofuscinosis neuronal 8, Rho guanine nucleotide exchange factor 10 and CUB and sushi multiple domains 1 may be candidate genes for DD/ID, microcephaly and neurobehavioral disorders.
|
28901431 |
2017 |
Carcinogenesis
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
RP11-397D12.4, AC007403.1, and ERICH1-AS1 may be potential biomarkers for predicting the tumorigenesis of NSCLC in the future.
|
26393913 |
2015 |
Northern epilepsy syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
Positional cloning and characterisation of the human DLGAP2 gene and its exclusion in progressive epilepsy with mental retardation.
|
10854099 |
2000 |
Isodicentric Chromosome 15 Syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
Oligonucleotide aCGH (oaCGH) showed that she had a classic inv dup del(8)(qter-> p23.1::p23.1-> p21.2) containing at least three candidate genes; MCPH1 and DLGAP2 within the 6.9-Mb terminal deletion and NEF3 within the concomitant 14.1-Mb duplication.
|
19793310 |
2009 |
Malignant Neoplasms
|
0.010 |
AlteredExpression
|
group |
BEFREE |
We discovered that three lncRNAs (RP11-397D12.4, AC007403.1, and ERICH1-AS1) were up regulated in NSCLC, compared with cancer-free controls, with the merged area under the curve in the training and validation sets of 0.986 and 0.861.
|
26393913 |
2015 |